Advertisement

Topics

Cross Atlantic Capital Partners Company Profile

19:55 EDT 21st June 2018 | BioPortfolio

Cross Atlantic Capital Partners is a venture capital firm investing in early- to mid-stage technology companies and has proven that it adds significant value to its portfolio companies. XACP’s philosophy that great companies are built over time and require attention to facets of their operations, has led XACP to participate in portfolio company developments, including management team recruitment, introductions, strategic and tactical management assistance, contact resources, expertise in private equity and public financing, and proactive exit management. For more information about Cross Atlantic Technology Partners, please visit www.xacp.com.


News Articles [1702 Associated News Articles listed on BioPortfolio]

Quartet unveils $40M fundraise and new collaboration with Horizon BCBSNJ

New York City-based Quartet has raised $40 million in a Series C round led by Polaris Partners and F-Prime Capital Partners. It also announced that it’s teaming up with a payer: Horizon Blue Cro...

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Centrexion raises $67mm in Series D round to fund Phase III trial for pain candidate CNTX4975

Pain-focused Centrexion Therapeutics Corp. raised $67mm in a Series D financing led by New Enterprise Associates. New and returning investors, including Quan Capital, ArrowMark Partners, investment fu...

Honest Buildings Expands Series B Round to $21M with Additional Real Estate-Owner Investments

They join existing Series B industry investors Brookfield Property Partners, Rudin Ventures and C-III Capital Partners, in addition to leading venture capital funds Navitas Capital, Read more...

CStone closes $260mm Series B round; largest in Chinese biopharm history

Immuno-oncology firm CStone Pharmaceuticals Co. Ltd. raised $260mm through its Series B round, the largest funding of its kind in Chinese biopharma history. GIC Private Ltd. led and was joined by new ...

M&As this week: Crescent Capital Partners, IPCA Laboratories Ltd

Crescent Capital Partners has acquired Nucleus Network Ltd from Baker IDI Heart and Diabetes Institute. The sale will help Baker...Read More... The post M&As this week: Crescent Capital Partners, ...

Medigene-Aktie: Leerverkäufer GSA Capital Partners hat den Rückwärtsgang eingelegt!

Martinsried - Leerverkäufer GSA Capital Partners LLP baut Netto-Leerverkaufsposition in Medigene-Aktien etwas ab: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP haben den Rückwärtsgang ...

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

PubMed Articles [1209 Associated PubMed Articles listed on BioPortfolio]

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

The dark side of social capital: A systematic review of the negative health effects of social capital.

There is a growing literature demonstrating the health benefits of social capital (defined as the resources accessed through social connections). However, social capital is also acknowledged to be a "...

A comparative study of social capital and hospital readmission in older adults.

Numerous factors contribute to hospital readmissions of older adults. The role social capital may play in preventing hospital readmissions is unknown. The aim of this descriptive, cross-sectional stud...

Investigating the Associations between Ethnic Networks, Community Social Capital, and Physical Health among Marriage Migrants in Korea.

This study examines factors associated with the physical health of Korea's growing immigrant population. Specifically, it focuses on the associations between ethnic networks, community social capital,...

Clinical Trials [1735 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

ID & Testing in Male Partners

This pilot study is a sub-study of ATN 067. ATN 067 utilizes a cross-sectional research design to recruit Latina and African American young women to undergo HIV screening. The primary goal...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Companies [2287 Associated Companies listed on BioPortfolio]

Cross Atlantic Capital Partners

Cross Atlantic Capital Partners is a venture capital firm investing in early- to mid-stage technology companies and has proven that it adds significant value to its portfolio comp...

Mid-Atlantic Dental Partners

“Mid-Atlantic Dental Partners will enable dentists to participate in improving the delivery of dental care by spending more time serving their patients instead of handling bi...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Skada Capital

Skada Capital (www.skadacapital.com) is a Maryland-based provider of financing solutions to healthcare, government contracting and technology companies in the Mid-Atlantic ...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

More Information about "Cross Atlantic Capital Partners" on BioPortfolio

We have published hundreds of Cross Atlantic Capital Partners news stories on BioPortfolio along with dozens of Cross Atlantic Capital Partners Clinical Trials and PubMed Articles about Cross Atlantic Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cross Atlantic Capital Partners Companies in our database. You can also find out about relevant Cross Atlantic Capital Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record